RA Capital Healthcare Fund, 10% Owner: Hemab Therapeutics Holdings COAG Buy · Filed 06/17

Trade details

Type: Insider buy
Amount: $152,973.94
Shares · price: 6,146 sh · $24.89 a share
Held after: 6,383,114 sh
Stock: Hemab Therapeutics Holdings COAG
Person: RA Capital Healthcare Fund10% Owner
Trade date: 26/06/15
Filed: 26/06/17
Days to filing: 2 days

First buy since 2023

Insiders buying this week: 4 insiders
Holding change: +0.1%

Hemab Therapeutics Holdings trades, last 26 weeks

What else happened in Hemab Therapeutics Holdings around then

Filed or reported within 30 days of the trade day · 05/16~07/15

RA Capital Healthcare Fund's recent trades

RA Capital Healthcare FundDirector, 10% Stockholder
Planned saleSionna Therapeutics
Planned sale
Sionna Therapeutics
SION
$21.8M
3,448,811 sh
$21.8M
Filed 09/17
Traded 09/17
RA Capital Healthcare FundDirector
Planned saleSepterna
Planned sale
Septerna
SEPN
$36M
746,500 sh
$36M
Filed 08/12
Traded 08/12
RA Capital Healthcare FundDirector
BuyArtiva Biotherapeutics
Buy
Artiva Biotherapeutics
ARTV
$275.3K
31,000 sh
$275.3K
Filed 06/29
Traded 06/25
RA Capital Healthcare FundDirector
BuyArtiva Biotherapeutics
Buy
Artiva Biotherapeutics
ARTV
$16.8K
1,876 sh
$16.8K
Filed 06/29
Traded 06/26
RA Capital Healthcare Fund10% Owner
SellWerewolf Therapeutics
Sell
Werewolf Therapeutics
HOWL
$136.2K
389,216 sh
$136.2K
Filed 06/22
Traded 06/17

RA Capital Healthcare Fund, 10% Owner — bought $153K of Hemab Therapeutics Holdings COAG · 6,146 sh @ $24.89 | Whalegun